Children's Liver Disease Foundation

Last updated

Children's Liver Disease Foundation (CLDF) is a UK charity taking action against the effects of childhood liver disease, providing information, emotional support, research funds and a voice for all affected.

Contents

CLDF was founded in 1980 by the parents of a little boy named Michael McGough, who died before be could receive a liver transplant. The name was later changed to Children's Liver Disease Foundation.

Today the charity works in four main areas, support of families and young people affected by childhood liver disease, funding medical and social research into all aspects of childhood liver disease and education, providing educational services to the general public and the medical profession and providing a voice for all affected by childhood liver disease. The charity works closely with the three UK specialist paediatric liver centres: Birmingham Children's Hospital, King's College Hospital, London and Leeds General Infirmary.

CLDF provides support to families and young people affected by childhood liver disease, including an ‘on-call’ telephone and email service and face to face meetings with parents and young people at hospitals and clinics.[ citation needed ]

The charity has also developed a range of literature for families, young people and healthcare professionals. CLDF's literature series includes a medical series, with leaflets on the main liver diseases affecting children (biliary atresia, alpha 1-antitrypsin deficiency, autoimmune hepatitis, hepatitis A, hepatitis B, hepatitis C, Wilson's disease etc.) CLDF has also produced a nutrition series, a support series for families and information written especially for children and young people. CLDF also provides the paediatric liver transplant units with a series of leaflets on transplantation to accompany the paediatric liver transplant programme.

Yellow Alert campaign

CLDF's prolonged jaundice awareness campaign, Yellow Alert aims to promote the early identification and appropriate referral of babies with prolonged jaundice – a sign of possible liver disease.

Related Research Articles

<span class="mw-page-title-main">Hepatitis</span> Inflammation of the liver

Hepatitis is inflammation of the liver tissue. Some people or animals with hepatitis have no symptoms, whereas others develop yellow discoloration of the skin and whites of the eyes (jaundice), poor appetite, vomiting, tiredness, abdominal pain, and diarrhea. Hepatitis is acute if it resolves within six months, and chronic if it lasts longer than six months. Acute hepatitis can resolve on its own, progress to chronic hepatitis, or (rarely) result in acute liver failure. Chronic hepatitis may progress to scarring of the liver (cirrhosis), liver failure, and liver cancer.

<span class="mw-page-title-main">Jaundice</span> Abnormal pigmentation symptom for disease of the liver

Jaundice, also known as icterus, is a yellowish or greenish pigmentation of the skin and sclera due to high bilirubin levels. Jaundice in adults is typically a sign indicating the presence of underlying diseases involving abnormal heme metabolism, liver dysfunction, or biliary-tract obstruction. The prevalence of jaundice in adults is rare, while jaundice in babies is common, with an estimated 80% affected during their first week of life. The most commonly associated symptoms of jaundice are itchiness, pale feces, and dark urine.

<span class="mw-page-title-main">Hepatology</span> Medical specialty

Hepatology is the branch of medicine that incorporates the study of liver, gallbladder, biliary tree, and pancreas as well as management of their disorders. Although traditionally considered a sub-specialty of gastroenterology, rapid expansion has led in some countries to doctors specializing solely on this area, who are called hepatologists.

<span class="mw-page-title-main">Alpha-1 antitrypsin deficiency</span> Medical condition

Alpha-1 antitrypsin deficiency is a genetic disorder that may result in lung disease or liver disease. Onset of lung problems is typically between 20 and 50 years of age. This may result in shortness of breath, wheezing, or an increased risk of lung infections. Complications may include chronic obstructive pulmonary disease (COPD), cirrhosis, neonatal jaundice, or panniculitis.

<span class="mw-page-title-main">Liver transplantation</span> Type of organ transplantation

Liver transplantation or hepatic transplantation is the replacement of a diseased liver with the healthy liver from another person (allograft). Liver transplantation is a treatment option for end-stage liver disease and acute liver failure, although availability of donor organs is a major limitation. The most common technique is orthotopic transplantation, in which the native liver is removed and replaced by the donor organ in the same anatomic position as the original liver. The surgical procedure is complex, requiring careful harvest of the donor organ and meticulous implantation into the recipient. Liver transplantation is highly regulated, and only performed at designated transplant medical centers by highly trained transplant physicians and supporting medical team. Favorable outcomes require careful screening for eligible recipients, as well as a well-calibrated live or deceased donor match.

<span class="mw-page-title-main">Alcoholic hepatitis</span> Medical condition

Alcoholic hepatitis is hepatitis due to excessive intake of alcohol. Patients typically have a history of at least 10 years of heavy alcohol intake, typically 8–10 drinks per day. It is usually found in association with fatty liver, an early stage of alcoholic liver disease, and may contribute to the progression of fibrosis, leading to cirrhosis. Symptoms may present acutely after a large amount of alcoholic intake in a short time period, or after years of excess alcohol intake. Signs and symptoms of alcoholic hepatitis include jaundice, ascites, fatigue and hepatic encephalopathy. Mild cases are self-limiting, but severe cases have a high risk of death. Severe cases may be treated with glucocorticoids. The condition often comes on suddenly and may progress in severity very rapidly.

<span class="mw-page-title-main">Autoimmune hepatitis</span> Chronic, autoimmune disease of the liver

Autoimmune hepatitis, formerly known as lupoid hepatitis, plasma cell hepatitis, or autoimmune chronic active hepatitis, is a chronic, autoimmune disease of the liver that occurs when the body's immune system attacks liver cells, causing the liver to be inflamed. Common initial symptoms may include fatigue, nausea, muscle aches, or weight loss or signs of acute liver inflammation including fever, jaundice, and right upper quadrant abdominal pain. Individuals with autoimmune hepatitis often have no initial symptoms and the disease may be detected by abnormal liver function tests and increased protein levels during routine bloodwork or the observation of an abnormal-looking liver during abdominal surgery.

<span class="mw-page-title-main">Alagille syndrome</span> Medical condition

Alagille syndrome (ALGS) is a genetic disorder that affects primarily the liver and the heart. Problems associated with the disorder generally become evident in infancy or early childhood. The disorder is inherited in an autosomal dominant pattern, and the estimated prevalence of Alagille syndrome is 1 in every 30,000 to 1 in every 40,000 live births. It is named after the French pediatrician Daniel Alagille, who first described the condition in 1969.

<span class="mw-page-title-main">Pediatric surgery</span> Medical subspecialty of surgery performed by pediatrics

Pediatric surgery is a subspecialty of surgery involving the surgery of fetuses, infants, children, adolescents, and young adults.

<span class="mw-page-title-main">Cirrhosis</span> Chronic disease of the liver, characterized by fibrosis

Cirrhosis, also known as liver cirrhosis or hepatic cirrhosis, and end-stage liver disease, is the impaired liver function caused by the formation of scar tissue known as fibrosis due to damage caused by liver disease. Damage to the liver leads to repair of liver tissue and subsequent formation of scar tissue. Over time, scar tissue can replace normal functioning tissue, leading to the impaired liver function of cirrhosis. The disease typically develops slowly over months or years. Early symptoms may include tiredness, weakness, loss of appetite, unexplained weight loss, nausea and vomiting, and discomfort in the right upper quadrant of the abdomen. As the disease worsens, symptoms may include itchiness, swelling in the lower legs, fluid build-up in the abdomen, jaundice, bruising easily, and the development of spider-like blood vessels in the skin. The fluid build-up in the abdomen may develop into spontaneous infections. More serious complications include hepatic encephalopathy, bleeding from dilated veins in the esophagus, stomach, or intestines, and liver cancer.

<span class="mw-page-title-main">Childhood cancer</span> Medical condition

Childhood cancer is cancer in a child. About 80% of childhood cancer cases in high-income countries, can be successfully treated thanks to modern medical treatments and optimal patient care. However, only about 10% of children diagnosed with cancer reside in high-income countries where the necessary treatments and care is available. Childhood cancer represents only about 1% of all types of cancers diagnosed in children and adults. For this reason, childhood cancer is often ignored in control planning, contributing to the burden of missed opportunities for its diagnoses and management in countries that are low- and mid-income.

The British Liver Trust is a charitable organisation in the United Kingdom which has a focus on the health of the liver. Based in Winchester, the Trust has over 20 employed members of staff who are supplemented by voluntary workers.

Jochen H.H. Ehrich is a German pediatric doctor in the fields of nephrology and tropical medicine, professor emeritus and Former Head of the Department of Paediatric Kidney, Liver and Metabolic Diseases at the Children’s Hospital, Hannover Medical School, in Hannover, Germany.

The VGM Gastro Centre is a specialist hospital located at Singanallur in Coimbatore, India. The centre was established in 2009 with 100 beds to treat patients and an intensive care unit. In 2012, former Tamil Nadu Governor Konijeti Rosaiah laid the foundation for a new block to house an advanced gastroenterology unit.

<span class="mw-page-title-main">Children's Cancer Foundation (Australia)</span>

The Children's Cancer Foundation is a registered Australian charity that supports children with cancer and their families.

<span class="mw-page-title-main">Podari Zhizn</span> Russian non-governmental charitable organization

Podari Zhizn is a countrywide Russian non-governmental charitable organization founded in 2006 by actresses Dina Korzun and Chulpan Khamatova. It has sister charities in the United Kingdom and in the United States (Podari.Life).

Alexander Parker Mowat was a Scottish paediatric hepatologist. He established the paediatric hepatology unit at King's College Hospital, London, which became a referral centre for children across Britain with liver diseases.

<span class="mw-page-title-main">2022 hepatitis of unknown origin in children</span> Disease outbreak

In 2022, cases of severe sudden hepatitis of unknown origin in children were reported to the World Health Organization (WHO) from several countries. The outbreak led to a significant interest in adenoviruses, though as of 2023 no definite explanation has been agreed on the cause of the hepatitis.

<span class="mw-page-title-main">Richard H. R. White</span> British paediatric nephrologist

Richard Henry Reeve White was a paediatric nephrologist, emeritus Professor of Paediatric Nephrology from the University of Birmingham morphologist and archivist for British Association for Paediatric Nephrology.

Deirdre Kelly is an Irish clinician, academic, and author. She is Professor of Paediatric Hepatology at the University of Birmingham and Clinical Lead for National Paediatric Hepatitis C Operational Delivery Network. She chairs the Board of Pension Trustees at the General Medical Council and is a non-executive director at NHS Blood and Transplant.

References